Monogram BioSciences, Inc. is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of infectious diseases, cancer and other serious diseases. The company’s molecular diagnostics and testing services enable healthcare providers to optimize treatment regimens for their patients and pharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics more efficiently. The company has developed HIV tests, or assays, to help make the complexities of antiretroviral therapy easier to manage, and oncology products to help accelerate the development of targeted cancer therapeutics.
In August 2009, Laboratory Corporation of America Holdings completed the acquisition of Monogram.